Losartan Recalled Due to Nitroso-N-methyl-4-aminobutyric Acid
An Additional Thirty-Two Lots of the Blood Pressure Medication Losartan Have Been Recalled UNITED STATES – According to an online news article published by www.miamiherald.com, an additional thirty-two lots of the heart and blood pressure medication Losartan has been recalled for evidence of contamination with a known … [Read more...] about Losartan Recalled Due to Nitroso-N-methyl-4-aminobutyric Acid
Able Laboratories Files for Chapter 11 Bankruptcy as Recalls, Layoffs, and Investigations Take Their Toll
Able Laboratories Files Bankruptcy. Over the past 14 years, Able has had many problems with the FDA including: over 10 drug recalls; charges of selling medications which were either adulterated, mislabeled, or with incorrect potency; failure to report serious adverse reactions with respect to at least five drugs; improper … [Read more...] about Able Laboratories Files for Chapter 11 Bankruptcy as Recalls, Layoffs, and Investigations Take Their Toll
Philippine FDA Announces Two Drug Recalls
The Philippine FDA Two Drug Recalls. The Food and Drug Administration (FDA) of the Philippines, in two separate advisories, has recalled specific lots and batches of two drug products: a cholesterol-lowering drug, and a drug used in the treatment of tuberculosis and other infections. In its advisories, the Philippine … [Read more...] about Philippine FDA Announces Two Drug Recalls
High Number Of Drug Recalls Leaving Consumers Numb
The high number of drug recalls is exhausting consumers. Last year, alone, consumers were faced with more than six recalls daily, said IndyStar.com, a worrisome statistic that has regulators and other experts concerned that consumers will ignore important recall information. In 2011, the United States consumer saw a massive 2,363 … [Read more...] about High Number Of Drug Recalls Leaving Consumers Numb
J&J Face Criticism Over Drug Recalls
Johnson & Johnson Face Criticism. The Food & Drug Administration (FDA) faced criticism yesterday from members of the House Committee on Oversight and Government Reform for having a relationship with drug maker Johnson & Johnson that some said may have been “too cozy.” Several on the committee asserted that this relationship … [Read more...] about J&J Face Criticism Over Drug Recalls
J&J CEO to Concede Mistakes in Drug Recalls
Johnson & Johnson Drug Recalls. Johnson & Johnson’s CEO Bill Weldon is schedule to testify before Congress today about his company’s handling of recalls of Children’s Tylenol and other drugs. According to The New York Times, Weldon’s prepared testimony for his appearance before the House Committee on Oversight and Government … [Read more...] about J&J CEO to Concede Mistakes in Drug Recalls
